Indoco Remedies (BOM:532612) COGS-to-Revenue : 0.28 (As of Mar. 2025)

View and export this data going back to 2005. Start your Free Trial

What is Indoco Remedies COGS-to-Revenue?

Indoco Remedies's Cost of Goods Sold for the three months ended in Mar. 2025 was ₹1,060 Mil. Its Revenue for the three months ended in Mar. 2025 was ₹3,839 Mil.

Indoco Remedies's COGS to Revenue for the three months ended in Mar. 2025 was 0.28.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Indoco Remedies's Gross Margin % for the three months ended in Mar. 2025 was 72.40%.

Indoco Remedies COGS-to-Revenue Historical Data

The historical data trend for Indoco Remedies's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indoco Remedies COGS-to-Revenue Chart

Indoco Remedies Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

COGS-to-Revenue

Get a 7-Day Free Trial

0.30

0.32

0.33

0.31

0.30

Indoco Remedies Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
COGS-to-Revenue	Get a 7-Day Free Trial															0.32	0.33	0.32	0.28	0.28

Indoco Remedies COGS-to-Revenue Calculation

Indoco Remedies's COGS to Revenue for the fiscal year that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	4981.8	/	16412.9
	=	0.30

Indoco Remedies's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1059.7	/	3838.9
	=	0.28

Indoco Remedies (BOM:532612) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Indoco Remedies's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	1059.7 / 3838.9
	=	72.40 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Indoco Remedies COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Indoco Remedies's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Indoco Remedies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indoco Remedies Ltd (BOM:532612) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

INDOCO:India

Address

166 CST Road, Indoco House, Kalina, Santacruz (East), Mumbai, MH, IND, 400 098

Website

https://www.indoco.com

Indoco Remedies Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The company manufactures products for different therapeutic sectors including Gastroenterology, Dentistry & Stomatology, Respiratory, Diabetology, Women's Health, Nutritional products, Cardiology, Metabolic Disorders, and Primary Care medicines. The only operating segment of the company is Pharmaceutical Products. Geographically, it generates the majority of the revenue from India.

Indoco Remedies Headlines

No Headlines